Australian Clinical Labs
ACL.AX
#6702
Rank
S$0.63 B
Marketcap
$3.14
Share price
-1.64%
Change (1 day)
35.65%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2023: $0.16

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is $0.16. In 2023 the company made an earnings per share (EPS) of $0.16 a decrease over its 2022 EPS that were of $0.81.

EPS history for Australian Clinical Labs from 2021 to 2023

Annual EPS

Year EPS Change
2023$0.16-80.55%
2022$0.81104.3%
2021$0.40